↓ Skip to main content

Cochrane Database of Systematic Reviews

Fluvoxamine for the treatment of COVID‐19

Overview of attention for article published in Cochrane database of systematic reviews, September 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
twitter
39 X users
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
115 Mendeley
Title
Fluvoxamine for the treatment of COVID‐19
Published in
Cochrane database of systematic reviews, September 2022
DOI 10.1002/14651858.cd015391
Pubmed ID
Authors

John Lz Nyirenda, Mario Sofroniou, Ingrid Toews, Agata Mikolajewska, Cornelius Lehane, Ina Monsef, Aesha Abu-Taha, Andy Maun, Miriam Stegemann, Christine Schmucker

X Demographics

X Demographics

The data shown below were collected from the profiles of 39 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 115 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 8 7%
Researcher 8 7%
Other 7 6%
Student > Bachelor 7 6%
Student > Master 7 6%
Other 17 15%
Unknown 61 53%
Readers by discipline Count As %
Medicine and Dentistry 20 17%
Unspecified 8 7%
Nursing and Health Professions 4 3%
Economics, Econometrics and Finance 4 3%
Neuroscience 4 3%
Other 13 11%
Unknown 62 54%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 January 2024.
All research outputs
#1,229,945
of 25,392,582 outputs
Outputs from Cochrane database of systematic reviews
#2,572
of 11,487 outputs
Outputs of similar age
#27,364
of 432,839 outputs
Outputs of similar age from Cochrane database of systematic reviews
#37
of 96 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,487 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 39.9. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 432,839 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.